|
|
||||||||
The FASEB Journal, Vol 7, 896-903, Copyright © 1993 by The Federation of American Societies for Experimental Biology
REVIEWS |
FJ Rauscher 3d
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.
Alteration of transcription factor function is becoming a common theme in molecular mechanisms of oncogenesis. A recent example of this trend is the isolation and characterization of the chromosome 11p13 Wilms tumor suppressor gene, WT1. The WT1 protein contains a DNA binding domain consisting of four zinc fingers of the Cys2-His2 class and a proline-glutamine rich region capable of regulating transcription. Deletions of the WT1 gene or point mutations which destroy the DNA binding activity of the protein are associated with the development of the pediatric nephroblastoma Wilms tumor and Denys-Drash syndrome. This article reviews the role of WT1 in normal kidney development processes, the known biochemical functions of the protein and the status of identifying target genes regulated by this potentially oncogenic transcription factor.
This article has been cited by other articles:
![]() |
Y. Bor, J. Swartz, A. Morrison, D. Rekosh, M. Ladomery, and M.-L. Hammarskjold The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron Genes & Dev., June 15, 2006; 20(12): 1597 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Santangelo Glucose Signaling in Saccharomyces cerevisiae Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 253 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wagner, K.-D. Wagner, H. Theres, C. Englert, A. Schedl, and H. Scholz Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1 Genes & Dev., November 1, 2005; 19(21): 2631 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Reizner, S. Maor, R. Sarfstein, S. Abramovitch, W. V Welshons, E. M Curran, A. V Lee, and H. Werner The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-{alpha} and regulates IGF-I receptor gene transcription in breast cancer cells J. Mol. Endocrinol., August 1, 2005; 35(1): 135 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Orloff, S. K. Iyengar, C. A. Winkler, K. A. B. Goddard, R. A. Dart, T. S. Ahuja, M. Mokrzycki, W. A. Briggs, S. M. Korbet, P. L. Kimmel, et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population Physiol Genomics, April 14, 2005; 21(2): 212 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Scholz and K. M. Kirschner A Role for the Wilms' Tumor Protein WT1 in Organ Development Physiology, February 1, 2005; 20(1): 54 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shahrabani-Gargir, T. K. Pandita, and H. Werner Ataxia-Telangiectasia Mutated Gene Controls Insulin-Like Growth Factor I Receptor Gene Expression in a Deoxyribonucleic Acid Damage Response Pathway via Mechanisms Involving Zinc-Finger Transcription Factors Sp1 and WT1 Endocrinology, December 1, 2004; 145(12): 5679 - 5687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Azuma, T. Otsuki, K. Kuzushima, C. J. Froelich, S. Fujita, and M. Yasukawa Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes Clin. Cancer Res., November 1, 2004; 10(21): 7402 - 7412. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, A. J. Bench, G. S. Vassiliou, N. Fourouclas, A. C. Ferguson-Smith, and A. R. Green Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies PNAS, May 11, 2004; 101(19): 7341 - 7346. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bentov, D. LeRoith, and H. Werner The WT1 Wilms' Tumor Suppressor Gene: A Novel Target for Insulin-Like Growth Factor-I Action Endocrinology, October 1, 2003; 144(10): 4276 - 4279. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Harley, M. J. Clarkson, and A. Argentaro The Molecular Action and Regulation of the Testis-Determining Factors, SRY (Sex-Determining Region on the Y Chromosome) and SOX9 [SRY-Related High-Mobility Group (HMG) Box 9] Endocr. Rev., August 1, 2003; 24(4): 466 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Ragione, V. Cucciolla, V. Criniti, S. Indaco, A. Borriello, and V. Zappia p21Cip1 Gene Expression Is Modulated by Egr1: A NOVEL REGULATORY MECHANISM INVOLVED IN THE RESVERATROL ANTIPROLIFERATIVE EFFECT J. Biol. Chem., June 20, 2003; 278(26): 23360 - 23368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Cheema, S. K. Mishra, V. M. Rangnekar, A. M. Tari, R. Kumar, and G. Lopez-Berestein Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter J. Biol. Chem., May 23, 2003; 278(22): 19995 - 20005. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Wagner, N. Wagner, and A. Schedl The complex life of WT1 J. Cell Sci., May 1, 2003; 116(9): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Fukuzawa, J Sakamoto, R W Heathcott, and J-I Hata A necropsy case of Denys-Drash syndrome with a WT1 mutation in exon 7 J. Med. Genet., August 1, 2002; 39(8): e48 - 48. [Full Text] [PDF] |
||||
![]() |
M. C. Gubler WT1, a Multiform Protein. Contribution of Genetic Models to the Understanding of its Various Functions J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2192 - 2194. [Full Text] [PDF] |
||||
![]() |
M. Makita, A. Hiraki, T. Azuma, A. Tsuboi, Y. Oka, H. Sugiyama, S. Fujita, M. Tanimoto, M. Harada, and M. Yasukawa Antilung Cancer Effect of WT1-specific Cytotoxic T Lymphocytes Clin. Cancer Res., August 1, 2002; 8(8): 2626 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Elisseeva, Y. Oka, A. Tsuboi, K. Ogata, F. Wu, E. H. Kim, T. Soma, H. Tamaki, M. Kawakami, Y. Oji, et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies Blood, May 1, 2002; 99(9): 3272 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Makrigiannakis, G. Coukos, A. Mantani, P. Prokopakis, G. Trew, R. Margara, R. Winston, and J. White Expression of Wilms' Tumor Suppressor Gene (WT1) in Human Endometrium: Regulation through Decidual Differentiation J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5964 - 5972. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calogero, A. Arcella, G. De Gregorio, A. Porcellini, D. Mercola, C. Liu, V. Lombari, M. Zani, G. Giannini, F. M. Gagliardi, et al. The Early Growth Response Gene EGR-1 Behaves as a Suppressor Gene That Is Down-Regulated Independent of ARF/Mdm2 but not p53 Alterations in Fresh Human Gliomas Clin. Cancer Res., September 1, 2001; 7(9): 2788 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. WAGNER, N. WAGNER, V. P. SUKHATME, and H. SCHOLZ Activation of Vitamin D Receptor by the Wilms' Tumor GeneProduct Mediates Apoptosis of Renal Cells J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1188 - 1196. [Abstract] [Full Text] |
||||
![]() |
M. A. Ghanem, T. H. Van der Kwast, J. C. Den Hollander, M. K. Sudaryo, M. H. A. Oomen, M. A. Noordzij, M. M. Van den Heuvel, S. M. Nassef, R. M. Nijman, and G. J. Van Steenbrugge Expression and Prognostic Value of Wilms' Tumor 1 and Early Growth Response 1 Proteins in Nephroblastoma Clin. Cancer Res., November 1, 2000; 6(11): 4265 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MROWKA and A. SCHEDL Wilms' Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 106S - 115. [Abstract] [Full Text] |
||||
![]() |
J. Liu, M. M. Nau, J. C. Yeh, C. J. Allegra, E. Chu, and J. J. Wright Molecular Heterogeneity and Function of EWS-WT1 Fusion Transcripts in Desmoplastic Small Round Cell Tumors Clin. Cancer Res., September 1, 2000; 6(9): 3522 - 3529. [Abstract] [Full Text] |
||||
![]() |
E. A. McGee and A. J. W. Hsueh Initial and Cyclic Recruitment of Ovarian Follicles Endocr. Rev., April 1, 2000; 21(2): 200 - 214. [Abstract] [Full Text] |
||||
![]() |
A. Makrigiannakis, K. Amin, G. Coukos, J. L. Tilly, and C. Coutifaris Regulated Expression and Potential Roles of p53 and Wilms' Tumor Suppressor Gene (WT1) during Follicular Development in the Human Ovary J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 449 - 459. [Abstract] [Full Text] |
||||
![]() |
H. Ohminami, M. Yasukawa, and S. Fujita HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide Blood, January 1, 2000; 95(1): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koziell and R. Grundy Frasier and Denys-Drash syndromes: different disorders or part of a spectrum? Arch. Dis. Child., October 1, 1999; 81(4): 365 - 369. [Full Text] |
||||
![]() |
A. J. A. Groffen, J. H. Veerkamp, L. A. H. Monnens, and L. P. W. J. van den Heuvel Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2119 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Falls, D. J. Pulford, A. A. Wylie, and R. L. Jirtle Genomic Imprinting: Implications for Human Disease Am. J. Pathol., March 1, 1999; 154(3): 635 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Silverman and T. Collins Pathways of Egr-1-Mediated Gene Transcription in Vascular Biology Am. J. Pathol., March 1, 1999; 154(3): 665 - 670. [Full Text] [PDF] |
||||
![]() |
S.-Y. Chun, E. A. McGee, S. Y. Hsu, S. Minami, P. S. LaPolt, H. H.-C. Yao, J. M. Bahr, A. Gougeon, D. W. Schomberg, and A. J.W. Hsueh Restricted Expression of WT1 Messenger Ribonucleic Acid in Immature Ovarian Follicles: Uniformity in Mammalian and Avian Species and Maintenance during Reproductive Senescence Biol Reprod, February 1, 1999; 60(2): 365 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, C. Jeanpierre, G. R. Dressler, M. Lacoste, P. Niaudet, and M.-C. Gubler WT1 and PAX-2 Podocyte Expression in Denys-Drash Syndrome and Isolated Diffuse Mesangial Sclerosis Am. J. Pathol., January 1, 1999; 154(1): 181 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagata, K.-i. Nakayama, Y. Terada, S. Hoshi, and T. Watanabe Cell Cycle Regulation and Differentiation in the Human Podocyte Lineage Am. J. Pathol., November 1, 1998; 153(5): 1511 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Stayner, H. E. Cunliffe, T. A. Ward, and M. R. Eccles Cloning and Characterization of the Human PAX2 Promoter J. Biol. Chem., September 25, 1998; 273(39): 25472 - 25479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Johnstone, J. Wang, N. Tommerup, H. Vissing, T. Roberts, and Y. Shi Ciao 1 Is a Novel WD40 Protein That Interacts with the Tumor Suppressor Protein WT1 J. Biol. Chem., May 1, 1998; 273(18): 10880 - 10887. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maheswaran, C. Englert, G. Zheng, S. B. Lee, J. Wong, D. P. Harkin, J. Bean, R. Ezzell, A. J. Garvin, R. T. McCluskey, et al. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70 Genes & Dev., April 15, 1998; 12(8): 1108 - 1120. [Abstract] [Full Text] |
||||
![]() |
G. B. Silberstein, K. Van Horn, P. Strickland, C. T. Roberts Jr., and C. W. Daniel Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer PNAS, July 22, 1997; 94(15): 8132 - 8137. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dong, R. Rajah, T. Vu, A. R. Hoffman, R. G. Rosenfeld, C. T. Roberts Jr., D. M. Peehl, and P. Cohen Decreased Expression of Wilms' Tumor Gene WT-1 and Elevated Expression of Insulin Growth Factor-II (IGF-II) and Type 1 IGF Receptor Genes in Prostatic Stromal Cells from Patients with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2198 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Plymate, V. L. Bae, L. Maddison, L. S. Quinn, and J. L. Ware Reexpression of the Type 1 Insulin-Like Growth Factor Receptor Inhibits the Malignant Phenotype of Simian Virus 40 T Antigen Immortalized Human Prostate Epithelial Cells Endocrinology, April 1, 1997; 138(4): 1728 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karnieli, H. Werner, F. J. Rauscher III, L. E. Benjamin, and D. LeRoith The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1Fusion Protein J. Biol. Chem., August 9, 1996; 271(32): 19304 - 19309. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bruening and J. Pelletier A Non-AUG Translational Initiation Event Generates Novel WT1 Isoforms J. Biol. Chem., April 12, 1996; 271(15): 8646 - 8654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Williams, L. M. Khachigian, T. Shows, and T. Collins Isolation and Characterization of a Novel Zinc-finger Protein with Transcriptional Repressor Activity J. Biol. Chem., September 22, 1995; 270(38): 22143 - 22152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Coppes, D. A. Haber, and P. E. Grundy Genetic Events in the Development of Wilms' Tumor N. Engl. J. Med., September 1, 1994; 331(9): 586 - 590. [Full Text] |
||||
![]() |
W. Wang, S. B. Lee, R. Palmer, L. W. Ellisen, and D. A. Haber A Functional Interaction with CBP Contributes to Transcriptional Activation by the Wilms Tumor Suppressor WT1 J. Biol. Chem., May 11, 2001; 276(20): 16810 - 16816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |